This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Choosing the Right Pacing Mode in Heart Failure - The CHOICE Trial (CHOICE)

This study has been completed.
Sponsor:
Collaborators:
Chest, Heart and Stroke Association Scotland
St. Jude Medical
Information provided by (Responsible Party):
AChoy, University of Dundee
ClinicalTrials.gov Identifier:
NCT00875732
First received: March 31, 2009
Last updated: July 7, 2017
Last verified: July 2017
  Purpose

The aim of the study is to see if biventricular pacemakers offer any advantage over conventional pacemakers in patients with heart failure who require pacemakers. The endpoints will be the 6 minute walking distance along with markers of cardiovascular function.

The investigators' hypothesis is that biventricular pacing is preferable to conventional pacing in these heart failure patients.


Condition Intervention
Heart Failure Device: Bi Ventricular Pacing Device: Right Ventricular Pacing

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: CHOosing the rIght paCing Mode in Heart failurE : Should Heart Failure Patients With Bradycardia Receive Biventricular Pacemakers Rather Than Conventional Pacemakers?

Resource links provided by NLM:


Further study details as provided by AChoy, University of Dundee:

Primary Outcome Measures:
  • 6 minute hall walk test [ Time Frame: Baseline, 3, 6, 9 and 12 months ]

Secondary Outcome Measures:
  • Endothelial Function [ Time Frame: Baseline, 3, 6, 9 and 12 months ]
  • Cardiac Output [ Time Frame: Baseline, 3, 6, 9 and 12 months ]

Enrollment: 22
Study Start Date: September 2009
Study Completion Date: January 2011
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Biventricular Pacing
Device: Bi Ventricular Pacing
Active Comparator: 2
Right Ventricular Pacing
Device: Right Ventricular Pacing

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Left ventricular systolic dysfunction.
  2. Atrio-ventricular node disease.
  3. Anticipated to be more than 40% paced, (including patients in permanent atrial fibrillation).
  4. Ability to walk independently (walking aid permitted).

Exclusion Criteria:

  1. Patients meeting criteria for CRT by current guidelines will be excluded.
  2. Life expectancy less than12 months.
  3. Inability to walk independently.
  4. Patients not likely to be compliant with follow-up.
  5. Bradyarrhythmia due with sino-atrial disease only.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00875732

Locations
United Kingdom
Ninewells Hospital & Medical School
Dundee, UK, United Kingdom, DD1 9SY
Sponsors and Collaborators
University of Dundee
Chest, Heart and Stroke Association Scotland
St. Jude Medical
  More Information

Responsible Party: AChoy, Dr. Anna Maria Choy, University of Dundee
ClinicalTrials.gov Identifier: NCT00875732     History of Changes
Other Study ID Numbers: ELD001
Study First Received: March 31, 2009
Last Updated: July 7, 2017

Keywords provided by AChoy, University of Dundee:
Resynchronization
Device
Bradycardia
atrioventricular block
Cardiac Resynchronization

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 19, 2017